Clinical trial
Clinical and Immune-modulating Effects of CC-10004 in Discoid Lupus Erythematosus
NCT00708916 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical and Immune-modulating Effects of CC-10004 in Discoid Lupus Erythematosus
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- August 31, 2010
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
discoid lupus erythematosus